Page last updated: 2024-08-23

paclitaxel and Hyperpigmentation

paclitaxel has been researched along with Hyperpigmentation in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bababeygy, SR; Haider, A; Lu, SY	1
Boulinguez, S; Gadaud, N; Gladieff, L; Guenounou, S; Lamant, L; Masson Regnault, M; Recher, C; Roche, H; Sibaud, V; Tournier, E	1
Barnett, D; Oldham, RK; Reid, WK	1
Schrijvers, D; Van Den Brande, J; Vermorken, JB	1

Reviews

1 review(s) available for paclitaxel and Hyperpigmentation

Article	Year
Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature. Dermatology (Basel, Switzerland), 2015, Volume: 231, Issue:4 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Eruptions; Female; Humans; Hyperpigmentation; Idarubicin; Lomustine; Male; Middle Aged; Paclitaxel; Vincristine	2015

Article

Year

Dermatology (Basel, Switzerland), 2015, Volume: 231, Issue:4

Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Eruptions; Female; Humans; Hyperpigmentation; Idarubicin; Lomustine; Male; Middle Aged; Paclitaxel; Vincristine

2015

Trials

1 trial(s) available for paclitaxel and Hyperpigmentation

Article	Year
Phase I study of CBT-1 and Taxol in patients with Taxol resistant cancers. Cancer biotherapy & radiopharmaceuticals, 2000, Volume: 15, Issue:2 Topics: Adult; Aged; Alkaloids; Antineoplastic Agents, Phytogenic; Biological Factors; Bone Marrow Diseases; Combined Modality Therapy; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gastrointestinal Diseases; Humans; Hyperpigmentation; Male; Middle Aged; Neoplasms; Paclitaxel; Salvage Therapy; Treatment Outcome	2000

Article

Year

Phase I study of CBT-1 and Taxol in patients with Taxol resistant cancers.

Cancer biotherapy & radiopharmaceuticals, 2000, Volume: 15, Issue:2

Topics: Adult; Aged; Alkaloids; Antineoplastic Agents, Phytogenic; Biological Factors; Bone Marrow Diseases; Combined Modality Therapy; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gastrointestinal Diseases; Humans; Hyperpigmentation; Male; Middle Aged; Neoplasms; Paclitaxel; Salvage Therapy; Treatment Outcome

2000

Other Studies

2 other study(ies) available for paclitaxel and Hyperpigmentation

Article	Year
Cystoid macular edema and macular pigmentation associated with nab-Paclitaxel therapy. Retinal cases & brief reports, 2015,Summer, Volume: 9, Issue:3 Topics: Aged; Albumins; Antineoplastic Agents, Phytogenic; Humans; Hyperpigmentation; Macular Edema; Macular Pigment; Male; Paclitaxel; Retinal Diseases	2015
Supravenous discoloration of the skin due to docetaxel treatment. The British journal of dermatology, 2000, Volume: 142, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Humans; Hyperpigmentation; Male; Middle Aged; Paclitaxel; Taxoids	2000